Drug profile · INN
alemtuzumab
LEMTRADA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
alemtuzumab (LEMTRADA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN alemtuzumab
Brand LEMTRADA
Route INJECTION
Formulation INJECTABLE
ATC code L04AA34
Frequently asked questions
What is alemtuzumab?
alemtuzumab (LEMTRADA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for alemtuzumab?
LEMTRADA is a marketed brand name for alemtuzumab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of alemtuzumab?
alemtuzumab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.